Please click on an icon to download a file. You can view and download presentations from other days of the conference by clicking on the links below:
Oral Research Presentations: Session 2 - Diagnosis, testing and epidemiology
Abstract O7: HIV testing in non-traditional settings – the HINTS study
Dr Michael Rayment, Chelsea and Westminster Hospital, London
Abstract O8: A study to assess the acceptability, feasibility and cost-effectiveness of universal HIV testing with newly registering patients (aged 16–59) in primary care
Dr Peter Wilkinson, NHS Brighton and Hove
Abstract O9: Community HIV testing: the feasibility and acceptability of assertive outreach and community testing to reduce late diagnosis of HIV
Dr Michael Brady, Terrence Higgins Trust
Abstract O10: Evaluation of a dry plasma matrix transport device for genotyping of HIV-1, HBV and HCV, and quantification of HIV-1 VL to provide an economic approach for real-time clinical care in resource-limited settings
Professor Clive Loveday, ICVC Charitable Trust, Buckinghamshire
Abstract O11: Drug levels and drug resistance after interruption of NNRTI-based HAART in the SMART trial
Dr Paola Vitiello, Royal Free Hampstead NHS Trust, London
Abstract O12: Dying of AIDS in the era of ART: A national audit
Ms Ruth Smith, Health Protection Agency, London
Abstract O13: Use of laboratory tests to study non-disclosure of HIV status within the unlinked anonymous survey in GUM clinics
Dr Emma Savage, Health Protection Agency, London
Abstract O14: An audit of HIV care provision for Immigration Removal Centre patients
Dr Kalpana Sabapathy, Hillingdon Hospital, London
Abstract O15: A retrospective analysis of HIV-positive patients diagnosed with sexually transmitted infection (STI) on asymptomatic screening: the risk to public health
Dr Martina Toby, St Thomas' Hospital, London
BHIVA Lunchtime Workshop 5
The itch to switch: opinion and options
Dr Ranjababu Kulasegaram, St Thomas’ Hospital, London
Oral Research Presentations: Session 3 - Co-infections and malignancies
Abstract O16: Increased incidence of multicentric Castleman’s disease in KSHV+ HIV-1+ individuals of black African ethnicity may result from the higher frequency of the TLR4 SNP A299G
Dr Samantha Westrop, Imperial College School of Medicine, London
Abstract O17: Chemoradiotherapy of anal cancer in HIV patients causes prolonged CD4 cell count suppression
Dr Maryam Alfa-Wali, Chelsea and Westminster Hospital, London
Abstract O18: Clinical features and outcome in 61 patients with HIV-associated multicentric Castleman’s disease
Dr Shairoz Merchant, Chelsea and Westminster Hospital, London
Abstract O19: HIV-infected patients with hepatocellular carcinoma (HCC) live longer if they have undetectable HIV RNA
Dr Emma Page, Chelsea and Westminster Hospital, London
Abstract O20: Treatment of acute hepatitis C infection in HIV-positive men who have sex with men: A ten-year experience at a single UK treatment centre
Dr Daniel Webster, Brighton and Sussex University Hospitals NHS Trust
Abstract O21: Acquisition of acute HCV in HIV-infected subjects is associated with cerebral disturbances but not increased microglial cell activation: a PET study
Dr Lucy Garvey, Imperial College Healthcare NHS Trust, London
Abstract O22: Hepatitis B virus co-infection in HIV-infected patients in the UK Collaborative HIV Cohort (UK CHIC) Study
Dr Huw Price, University College London
Abstract O23: Invasive Pneumococcal Disease among HIV-infected individuals in the last decade: population-based cohort study
Dr Zheng Yin, Health Protection Agency, London
Abstract O24: Whole-blood interferon-gamma release assay in the diagnosis of active tuberculosis infection in HIV-infected and HIV non-infected individuals: a five-year review of data
Dr Thomas Lavender, Newcastle-upon-Tyne Hospitals NHS Foundation Trust
BHIVA Audit Session
HIV testing and diagnosis
Dr Simon Ellis, Royal Victoria Infirmary, Newcastle
BHIVA Plenary Session 3 - Here to stay and here at last
Broken bones: is it worth the worry?
Dr Patrick Mallon, University College Dublin, Ireland
New challenges in drug management of HIV/hepatitis C co-infection
Professor Douglas Dieterich, Mount Sinai School of Medicine, New York, USA